USANA Health Sciences, Inc.USNANYSE

|||

Switch Symbol:

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

prnewswire.com

USANA Exec. Chairman/CEO Kevin Guest on Self-Renewal Day: Break Comfort Zones for Strategic Growth with Six Steps

SALT LAKE CITY, Feb. 2, 2026 /PRNewswire/ -- As organizations face rapid market disruption and evolving leadership demands, Feb. 2 marks Self-Renewal Day, a pivotal time for business leaders to recalibrate strategies and personal development. "Growth does not happen by accident; it happens by choice," said Kevin Guest, Executive Chairman & CEO at USANA Health Sciences (NYSE: USNA).

prnewswire.com

The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings

/PRNewswire/ -- The global consumer healthcare market is hitting a massive structural wall, projected to reach $362.17 billion in 2026[1]. In this high-stakes

feeds.newsfilecorp.com

Stonegate Attends ICR 2026, Highlighted by Fireside Chat with Nu Skin (NUS)

Dallas, Texas--(Newsfile Corp. - January 14, 2026) - Stonegate Capital Partners attended the 2026

businesswire.com

USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA's strategy, including the Company's initial fiscal year 2026 sales outlook. Preliminary Fiscal Year 2025 Net Sales Results The Company currently anticipates fiscal year 2025 cons.

businesswire.com

Kevin Guest Returns to USANA Health Sciences as CEO

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) announced today a leadership transition as part of the Company's ongoing commitment to accelerating growth and enhancing shareholder value. Kevin Guest is returning to lead the Company as Chief Executive Officer, effective immediately. Mr. Guest, who has spent more than three decades at the Company, including eight years as CEO and the last three years as Executive Chairman, has agreed to again serve as USANA's CEO and wi.

prnewswire.com

USANA Executive Chairman Kevin Guest Shares Timeless Lessons for a 2026 Growth Mindset

SALT LAKE CITY, Jan. 5, 2026 /PRNewswire/ -- As leaders everywhere set sights on the new year, Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA), is encouraging professionals to embrace a growth mindset as the key to lasting achievement and fulfillment. "Success is about the experiences you have, the relationships you build, and the lessons you apply," said Guest, who is also the author of the bestseller, All the Right Reasons: 12 Principles for Living a Life in Harmony.

prnewswire.com

USANA Foundation Shares Holiday Cheer with Meals for Utah Students and Families

More than 5,100 food bags delivered to help support children during winter break SALT LAKE CITY , Dec. 23, 2025 /PRNewswire/ -- The holiday season is meant to be a time of celebration, yet for many children who depend on school meals, extended breaks can bring uncertainty. To help bridge that gap, the USANA Foundation - through its Utah-focused Kids Eat program - once again mobilized its annual holiday food pack initiative to help ensure families across Utah had access to nutritious meals while school was out of session.

defenseworld.net

Analyzing NLS Pharmaceutics (NASDAQ:NCEL) & USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE: USNA - Get Free Report) and NLS Pharmaceutics (NASDAQ: NCEL - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Profitability This table compares USANA Health

prnewswire.com

Trust Your Gut--USANA's Probiotic Earns ConsumerLab.com Seal of Approval

SALT LAKE CITY , Dec. 16, 2025 /PRNewswire/ -- USANA (NYSE: USNA), the global leader in cellular nutrition, is proud to announce that its top-rated Probiotic supplement has earned the distinguished ConsumerLab.com Seal of Approval. This respected third-party certification recognizes products that meet the highest standards for purity, potency, and scientific accuracy.

defenseworld.net

Critical Analysis: USANA Health Sciences (NYSE:USNA) vs. NRx Pharmaceuticals (NASDAQ:NRXP)

USANA Health Sciences (NYSE: USNA - Get Free Report) and NRx Pharmaceuticals (NASDAQ: NRXP - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Volatility and Risk USANA Health Sciences

prnewswire.com

On National "Make-a-Gift Day," Kevin Guest Says the Most Meaningful Gifts Are the Ones Money Can't Buy

Creative gestures and shared experiences form the foundation of lasting love. SALT LAKE CITY , Dec. 3, 2025 /PRNewswire/ -- National Make a Gift Day (Dec. 3) is a call to generosity and intentionality, encouraging people to craft something meaningful for someone they care about.

prnewswire.com

Proven Power for Strong Bone Support--USANA's MagneCal D Earns ConsumerLab.com Seal of Approval

SALT LAKE CITY , Nov. 11, 2025 /PRNewswire/ -- USANA (NYSE: USNA), the global leader in cellular nutrition, is thrilled to announce that its fan-favorite MagneCal D supplement has officially earned the coveted ConsumerLab.com Seal of Approval—a gold-standard recognition for purity, potency, and scientific excellence.* With millions of Americans looking for ways to maintain their bone density, getting enough calcium, magnesium, and vitamin D isn't just a good idea—it's essential.

prnewswire.com

USANA Foundation Mobilizes Hundreds from the Community to Pack 3,000 Food Bags for Utah Families Affected by SNAP Cutbacks

Community-wide effort addresses growing food insecurity among Utah children and families SALT LAKE CITY , Nov. 6, 2025 /PRNewswire/ -- In a powerful response to growing food insecurity affecting Utah families and the recent federal SNAP cutbacks, the USANA Foundation joined forces with community partners and volunteers on Wednesday, November 5, to assemble 3,000 bags of food for children and families facing food insecurity. The large-scale event, held at the USANA Foundation Headquarters in West Valley City, brought together hundreds of volunteers from organizations including the Bountiful Food Pantry, For the Kids, the Utah Department of Cultural and Community Engagement, and Kristen Andrus' Gathering for Impact.

prnewswire.com

USANA Executive Chairman Kevin Guest Calls for a "Great Re-Engagement" Rooted in Trust, Empathy, Purpose

SALT LAKE CITY , Nov. 3, 2025 /PRNewswire/ -- As business leaders worldwide focus on re-energizing workforces after years of upheaval, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is urging CEOs to lead with renewed authenticity, empathy, and moral clarity—principles he calls "the real foundation of sustainable success." "No doubt, technology and strategy will always matter," Guest said.

prnewswire.com

Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

NEW YORK , Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE: KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE: USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30.

seekingalpha.com

USANA Health Sciences, Inc. (USNA) Q3 2025 Earnings Call Transcript

USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2025 Earnings Call October 23, 2025 11:00 AM EDT Company Participants Andrew Masuda - Director of Investor Relations Jim Brown - CEO & President Brent Neidig - Chief Commercial Officer G. Hekking - Chief Financial Officer Walter Noot - Chief Operating Officer Kathryn Armstrong Conference Call Participants Anthony Lebiedzinski - Sidoti & Company, LLC Susan Anderson - Canaccord Genuity Corp., Research Division Ivan Feinseth - Tigress Financial Partners LLC, Research Division Presentation Operator Greetings, and welcome to the USANA Health Sciences third quarter earnings call.

zacks.com

USANA Health Sciences (USNA) Reports Q3 Loss, Misses Revenue Estimates

USANA Health Sciences (USNA) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.56 per share a year ago.

businesswire.com

USANA Health Sciences Reports Third Quarter 2025 Results and Updates Full-Year Outlook

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 27, 2025. Key Financial Results Third Quarter 2025 vs. Third Quarter 2024 Net sales of $214 million versus $200 million, representing 7% year-over-year growth. Net loss of -$6.5 million versus net earnings of $10.6 million. Diluted EPS of -$0.36 as compared with $0.56. Adjusted diluted EPS(1) of -$0.15 as compared with $0.56. Adjusted EBITDA(2).

businesswire.com

USANA Updates the Timing of the Release of Third Quarter 2025 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) (“the Company,” “USANA”) today announced that it has updated the timing of the release of its third quarter 2025 financial results, which had previously been scheduled for Tuesday, October 21, 2025. The Company will now report third quarter 2025 financial results after the close of market on Wednesday, October 22, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management C.

prnewswire.com

USANA's Vitamin D Supplement Shines Bright with ConsumerLab.com Seal of Approval--Setting the Standard for Product Quality

SALT LAKE CITY , Oct. 16, 2025 /PRNewswire/ -- USANA (NYSE:USNA), a global leader in cellular nutrition, is bringing a little more sunshine to wellness. Its top-rated Vitamin D supplement has officially earned the prestigious ConsumerLab.com Seal of Approval—a recognition reserved for products that deliver on purity, potency, and scientific precision.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance